The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
